Leo Pharma AS - Company Profile
Powered by 
All the sales intelligence you need on Leo Pharma AS in one solution.
- Save hours of research time with a comprehensive
Sales Intelligence Solution.
- Understand how Leo Pharma AS fits into your total
addressable market and Ideal Customer Profile.
- Gain competitive edge with triggers that tell you
when and how to engage with Leo Pharma AS.
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
View up-to-date information on Leo Pharma AS patents, including inventor and filing insights.
Patent Trends
| Publication Identifier | Document Type | Title | Classification-CPC | Publication Date |
|---|---|---|---|---|
| RS64798B1 | Grant | Use of delgocitinib for the treatment of chronic hand eczema | A61K31/519; A61K47/06; A61K9/0014; A61K9/06; A61P17/00; A61P17/04; A61P43/00; C07D487/10 | November 30, 2023 |
| DK3405197T3 | Application | Topisk behandling af håndeksem | A61K31/519; A61K47/06; A61K9/0014; A61K9/06; A61P17/00; A61P17/04; A61P43/00; C07D487/10 | November 27, 2023 |
| LT3405197T | Grant | Use of delgocitinib for the treatment of chronic hand eczema | A61K31/519; A61K47/06; A61K9/0014; A61K9/06; A61P17/00; A61P17/04; A61P43/00; C07D487/10 | November 27, 2023 |
| FI3405197T3 | Grant | Use of delgocitinib for the treatment of chronic hand eczema | A61K31/519; A61K47/06; A61K9/0014; A61K9/06; A61P17/00; A61P17/04; A61P43/00; C07D487/10 | November 23, 2023 |
| AU2022278636A1 | Application | Anti il-1 receptor accessory protein antibodies | A61K2039/505; C07K16/2866; C07K2317/21; C07K2317/33; C07K2317/55; C07K2317/565; C07K2317/567; C07K2317/76; C07K2317/90; C07K2317/92; C07K2317/94 | November 16, 2023 |
Top Inventors by Filings (Count by publication)
| Name | Count |
|---|
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer